Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 428-570-1 | CAS number: 187585-64-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- When this study was performed, the LLNA did not yet exist as an OECD testing guideline.
- Specific details on test material used for the study:
- - Physical state: powder / grey-white
- Analytical purity: 95.8% (per weight; HPLC)
- Lot/batch No.: ZD 1151/ 31 (production: 03-Dec-1997)
- Storage condition of test material: refrigerator, protected from light. - Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Pirbright White, Dunkin Hartley CrI:(HA)BR [SPF] from Charles River GmbH, Sulzfeld, FRG
- Age at study initiation: young adult animals (male animals approx. 8- 12 weeks, female animals approx. 14-18 weeks)
- Weight at study initiation: animals of comparable weight (range: 335 - 373 g); actual weights: 345.8±7.4 mg for the control group 1, 360±5.0 mg for the control group 2 and 352.2±12.0 mg for the test group.
- Fasting period before study: the animals were given no feed at least 16 hours before administration, but water was available ad libitum.
- Housing: the animals were single-housed in fully air-conditioned rooms in Stainless steel wire mesh cages with plastic-coated grating, floor area 40 cm x 51 cm. The animals were identified individually using cage cards and group identification by tail marking. Identification with ear tattoo. No bedding in the Cages; wood shavings in the waste trays.
- Diet, ad libitum: Kliba-Labordiaet, (Kaninchen-Meerschweinchen-Haltuflgsdiät; Firma Klingentalmühle AG, Kaiseraugst, Switzerland). The feed used in the study was assayed for chemical and microbiological contaminants. In view of the aim and duration of the study the contaminants occurring were seen as not likely to influence the results.
- Water, ad libitum: tap water. the drinking water is regularly assayed for chemical contaminants by the municipal authorities of Frankenthal and the technical services of BASF Aktiengesellschaft as well as for the presence of germs by a contract laboratory. In view of the aim and duration of the study the contaminants occurring were seen as not likely to influence the results.
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Central air-conditioning guaranteed a range of 21 - 25 degrees
- Humidity (%): 30 - 70 %
- Photoperiod (hrs dark / hrs light): 12/12 hours (6.00 am - 600 pm/ 6.00 pm - 6.00 am) - Route:
- other: intradermal and percutaneous occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- intradermal induction: 5% in olive oil; percutaneous induction: 25% in olive oil; percutaneous challenge: 25% in olive oil
- Route:
- epicutaneous, occlusive
- Vehicle:
- olive oil
- Concentration / amount:
- intradermal induction: 5% in olive oil; percutaneous induction: 25% in olive oil; percutaneous challenge: 25% in olive oil
- No. of animals per dose:
- Main test: 5 per control group and 10 in the test group
- Details on study design:
- RANGE FINDING TESTS:
1) Intradermal Pretest
- Amount applied:6 intradermal injections in groups of two per animal were applied to each animal. A) front row: 2 injections each of 0.1 ml Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCI-solution in a ratio of 1:1; B) middle row: 2 injections each of 0.1 ml of a test substance formulation in an appropriate vehicle at the selected concentration; C) back row: 2 injections each of 0.1 ml Freund's adjuvant 1 0.9% aqueous NaCI-solution (1: 1) with test substance at the selected concentration.
- Site of application: shoulder
- No. of animals: 2 per test substance concentration
- Reading: 24 h after the beginning of application
2) Percutaneous Pretest
- Amount applied: 2 x 2 cm gauze patches (6 Iayers surgical gauze) containing 0.5 ml of the test substance formulation were applied to the 5 cm of the flanks under an occlusive dressing. The dressing consisted of rubberized linen patches (4 x 4 cm from Russka), patches of Idealbinde (5 x 5 cm) and Fixomull Stretch (adhesive fleece).
- Exposure period: The test substance was applied 2 times for 24 hours within a period of 96 hours in order to detect non- specific phenomena that are not caused by a sensitization reaction but could possibly be attributed to a shift in the irritation threshold.
- Site of application: flank, on the same area respectively
- Number of test animals: 4 per test concentration
- Readings: 24 h and 48 h after the beginning of application
MAIN STUDY
A. INDUCTION EXPOSURE
1) Intradermal induction
- No. of exposures: 6 intradermal injections in groups of two per animal were given.
- Test groups: same as intradermal pretest
- Control group: A) front row: 2 injections each of 0.1 ml Freund's adjuvant without test substance emulsified with 0.9% aqueous NaCI-solution in a ratio of 1:1; B) middle row: 2 injections each of 0.1 ml of the undiluted vehicle; C) back row: 2 injections each of 0.1 ml of a 50% formulation of the vehicle without test substance emulsified with Freund's adjuvant /0.9% aqueous NaCI-solution (1:1)
- Site: shoulder
- Duration: reading done 24 h after the beginning of application
2) Percutaneous induction (carried out one week after intradermal induction)
- Amount applied: 2 x 4 cm gauze patches (6 layers surgical gauze) containing the test substance formulation were applied to the 5cm of the shoulder under an occlusive dressing. The dressing consisted of rubberized linen patches (4 x 6 cm) and Fixomull Stretch (adhesive fleece). 1 ml of the test substance formulation was applied to each animal.
The control groups were treated analogously to the test group but only with the vehicle without the test substance.
- Duration of exposure: 48 hours
- Site of application: shoulder, same area as in the case of the previous intradermal application
- Readings: 48 h after the beginning of application
B. CHALLENGE EXPOSURE
- No. of exposures: once
- Day(s) of challenge: the challenge was performed 14 days after the percutaneous induction.
- Exposure period: 24 hours
- Test groups: 2 x 2 cm gauze patches (6 Iayers surgical gauze) containing the test substance formulation were applied to the skin of the flank under an occlusive dressing. The dressing consisted of rubberized linen patohes (4 x 4 cm), patches of Idealbinde (5 x 5 cm) and Fixomull® Stretch (adhesive fleece) from Beiersdorf AG.
- Control group: same as test group
- Site: intact flank
- Concentrations: 0.5 ml of the test substance formulation was applied to each animal.
- Evaluation (hr after challenge): 24 and 48 h after the removal of the patch - Challenge controls:
- see above (Detail on study design)
- Positive control substance(s):
- yes
- Remarks:
- with Alpha-Hexylcinnamaldehyde techn. 85% showed that the test system was able to detect sensitizing compounds under the laboratory conditions chosen.
- Positive control results:
- the positive control substance showed consistent responses
- Reading:
- other: first (after 24 hours) and second (48 hours) readings
- Group:
- negative control
- Dose level:
- application of test substance (25% in olive oil) on the right flank and of olive oil only left flank
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no visible change induced
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: first (after 24 hours) and second (48 hours) readings. Group: negative control. Dose level: application of test substance (25% in olive oil) on the right flank and of olive oil only left flank. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no visible change induced.
- Reading:
- other: first (after 24 hours) and second (48 hours) readings
- Group:
- negative control
- Dose level:
- olive oil, left flank
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- no visible change induced
- Remarks on result:
- other: Reading: other: first (after 24 hours) and second (48 hours) readings. Group: negative control. Dose level: olive oil, left flank. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: no visible change induced.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- application of test substance (25% in olive oil) on the right flank and of olive oil only left flank
- No. with + reactions:
- 7
- Total no. in group:
- 10
- Clinical observations:
- animals that received the test substance: discrete or patchy erythema in 4, moderate and confluent erythema in 3 and no visible change in 3; animals that received olive oil only: no visible change
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: application of test substance (25% in olive oil) on the right flank and of olive oil only left flank. No with. + reactions: 7.0. Total no. in groups: 10.0. Clinical observations: animals that received the test substance: discrete or patchy erythema in 4, moderate and confluent erythema in 3 and no visible change in 3; animals that received olive oil only: no visible change.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- application of test substance (25% in olive oil) on the right flank and of olive oil only left flank
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- animals that received the test substance: discrete or patchy erythema in 5, moderate and confluent erythema in 1 (scaling and swelling also observed in the same animal) and no visible change in 4; animals that received olive oil only: no visible change
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: application of test substance (25% in olive oil) on the right flank and of olive oil only left flank. No with. + reactions: 6.0. Total no. in groups: 10.0. Clinical observations: animals that received the test substance: discrete or patchy erythema in 5, moderate and confluent erythema in 1 (scaling and swelling also observed in the same animal) and no visible change in 4; animals that received olive oil only: no visible change.
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
Reference
Intradermal induction:
- the animals in the first and second control group (each 5) all showed swelling as well as moderate and confluent erythema (when treated with Freund adjuvant/0.9% aqueous NaCl solution [1:1, 2 x 0.1 ml)] or with a 50% formulation of olive oil with Freund's adjuvant/0.9% aqueous NaCl solution [1:1, 2 x 0.1 ml]) or only moderate and confluent erythema (when treated with olive oil [2 x 0.1 ml]) 24 hours after the beginning of application.
- The animals in the test group (10, treated in the left and right flank with Freund adjuvant/0.9% aqueous NaCl solution [1:1, 2 x 0.1 ml)], with test substance 5% in olive oil [2 x 0.1 ml] or with test substance 5% in Freund's adjuvant/0.9% aqueous NaCl solution [1:1, 2 x 0.1 ml]) all showed swelling as well as moderate and confluent erythema 24 hours after the beginning of application.
Percutaneous induction:
All animals (in control groups 1 and 2 treated with olive oil, and in the test group treated with test substance 25% in olive oil) showed swelling, well as moderate and confluent erythema, as well as incrustation, partially open, 48 hours after the beginning of application.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
A guinea pig maximization test according to OECD guideline 406 was conducted. The test substance proofed to be sensitizing.
10 animals were challenged with the test substance (25% in olive oil) following intradermal (5%) and percutaneous induction (25%). 7/10 and 6/10 animals showed positive reactions at the 24 h and 48 h reading, respectively.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. Positive responses (60 – 70%) were observed in a guinea pig maximization test (OECD 406) after an intradermal induction with 5%. Since the induction concentration was greater than 1%, the substance is considered to be classified as a skin sensitizer of moderate potency under Regulation (EC) No. 1272/2008, as amended for the seventh time in Regulation (EC) No 2015/1221.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.